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Purpose: The purpose of this article was to announce the establishment of the multi-
center Korean Prostate Cancer Database (K-CaP) and to provide urologists with details 
about K-CaP’s methodology. 
Materials and Methods: The initial participating K-CaP institutions include five medi-
cal centers in Korea. First, we registered prostate cancer patients who underwent radi-
cal prostatectomy as the basic background data. K-CaP is poised to combine these initial 
observational longitudinal studies with those of other eligible institutions as the data-
base grows. All current prostate cancer patients in Korea are able to be registered into 
the Web-based database system and thereby have a role in several observational 
studies. The structure of the database for K-CaP was developed by matching it with 
the respective data from different studies. The operability of the K-CaP database sys-
tem was verified by using the existing databases from three participating institutions.
Results: The analysis of clinicopathologic characteristics of patients with the use of the 
Web-based database was successfully conducted. We confirmed the accurate operation 
of the Web-based database system without any difficulties. 
Conclusions: We are announcing the establishment of K-CaP the first database of com-
prehensive observational longitudinal studies about prostate cancer in Korea. The da-
tabase will be successfully maintained by sufficiently and continuously updating all 
patient data covering several treatments. Complete statistical results for registered 
prostate cancer patients are forthcoming for the basic background data to establish the 
database. Even though much trial and error are expected during the development proc-
ess, we expect that K-CaP will eventually become one of the most powerful longitudinal 
observation databases.
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The prevalence of prostate cancer in Korea quadrupled be-
tween 2002 and 2008, with the highest increased incidence 
rate in total forms of malignancy [1]. The incidence of pros-
tate cancer in Korea increased up to 24.8 per 100,000 men 
in 2009 in comparison with 13 per 100,000 men in 2008 [2]. 
Certain environmental elements have had an effect on the 
increased rate of prostate cancer, including the transition 
to Western dietary habits among Koreans and an aging 
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population because of the rise in average life expectancy. 
In addition to environmental causes, the medical develop-
ment of laboratory diagnoses and prostate-specific antigen 
screening campaigns by the Korean Urological Association 
and other health organizations have helped to raise public 
awareness about the increase in prostate cancer in 
Koreans [2,3]. 
Despite the rapid increase in prostate cancer incidence 
in Korea, no published multicenter data on practical and 
clinical changes in Korean patients with prostate cancer 
are available. In the United States, a database application 
project known as the Cancer of the Prostate Strategic 
Urologic Research Endeavor (CaPSURE) was initiated in 
1995 to establish a web-based database for longitudinal ob-
servations of prostate cancer patients in natural settings 
[4]. The project began with 10 participating healthcare cen-
ters and increased to 26 centers in 1 year. Currently, 
CaPSURE is one of the most powerful prospective study 
groups for prostate cancer in the world consisting of ap-
proximately 14,000 registered prostate cancer patients [5]. 
The most recent database study in Asia, the Japan Study 
Group for Prostate Cancer (J-CaP), was developed in 2001 
[6]. The J-CaP database comprises 17,872 prostate cancer 
patients from prospective studies and was developed to im-
prove patient care. 
Against this background, the multicenter Korean pros-
tate cancer database (K-CaP) was created in 2011 by com-
bining several urologic healthcare institutions into a na-
tionwide multicenter database for prospective studies 
about prostate cancer. The purpose of K-CaP is to gather 
basic information about Korean prostate cancer patients 
and analyze the clinical and oncological outcomes of pros-
tate cancer to improve patient care. The purpose of this ar-
ticle was to declare the establishment of K-CaP, to provide 
urologists with an overview of the K-CaP methodology, and 
to present pilot test results from the first umbrella data-
base comprising patient information from three participat-
ing institutions (Gangnam Severance Hospital, Seoul St. 
Mary’s Hospital, and Seoul National University Bundang 
Hospital).
MATERIALS AND METHODS
1. Organization of K-CaP 
1) Participating institutions (in alphabetical order)
Participating institutions include Asan Medical Center, 
Samsung Medical Center, Seoul National University 
Bundang Hospital, Seoul St. Mary’s Hospital, and Yonsei 
University Severance Hospital.
2) Eligible institutions
Eligible institutions include all urologic institutions in 
Korea. Any institution that wants to participate in K-CaP 
must first obtain approval from their ethics committees (or 
Institutional Review Board). For every eligible institution, 
all patients with newly diagnosed prostate cancer will be 
registered in the K-CaP web-based electronic server. All 
registered patient information will be updated perio-
dically. 
2. Data collection, entry, follow-up, and retrieval
1) Data collection
After a diagnosis of prostate cancer, patients are invited by 
their urologists to join the study. All patients with biop-
sy-proven prostate cancer are offered enrollment in the 
study, regardless of disease stage, severity, or type of 
treatment. Included in the database is all of the physi-
cian-gathered general information about a patient, includ-
ing sociodemographic data. In addition, all of the patient’s 
clinical information at diagnosis is gathered, including di-
agnostic imaging, laboratory test results, pre-existing and 
postdiagnosis comorbidities, medical history, treatment 
types (e.g., active surveillance, androgen deprivation/hor-
monal medications, brachytherapy, cryotherapy, external 
beam radiation, hormone refractory and chemotherapy 
agents, and radical prostatectomy), neoadjuvant and ad-
juvant treatments, and other nontreatment-related medi-
cations. For patients who have undergone radical prosta-
tectomy, detailed perioperative variables are measured 
and registered, including procedure types, intraoperative 
or postsurgical complications, surgical pathology results, 
and clinical and oncological survival outcomes. The patient 
files for the K-CaP database include approximately 1,000 
required clinical variables. 
2) Entry
The observational study of prostate cancer patients is the 
ultimate goal of the K-CaP database. Accordingly, the 
web-based electronic case report form (e-CRF) was devel-
oped by using the StarTrial system, which is a commer-
cially developed electronic data capture system. This 
e-CRF system can be accessed over the Internet on a 
24-hour basis by coordinators and investigators at eight 
participating clinics (Suppl. 1). Suppl. 1A is a screenshot 
of registration for prostate cancer patients. Suppl. 1B is a 
screenshot of the baseline parameters of the registered 
patients. The system was developed at the Catholic 
University of Korea, South Korea, and was previously test-
ed with the help of staff at other participating sites. The da-
tabase system was implemented with a Microsoft SQL 
Server running on Microsoft NT servers and was pro-
grammed with Java. This was accomplished by directly 
partnering the electronic databases of the study’s partic-
ipating institutions with the registered patient files. All le-
gal requirements for privacy protection were respected in 
this procedure. 
3) Follow-up
According to the privacy rules of K-CaP, cases for regis-
tered patients are to be updated once every 3 months in 
terms of test dates, changes in treatment, and progress da-
ta as a matter of course for maintaining the K-CaP patient 
forms until death or patient withdrawal. Follow-up with 
respect to morbidity and death from prostate cancer is as-
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sured by cooperation with national statistics. When pa-
tients die, the date, location, and cause of death are re-
corded in the database. 
4) Data retrieval
After completion of the data control for registered patients, 
analytic reports are prepared for prospective studies and 
research to improve the care of prostate cancer patients. 
These data summaries evaluate clinical occurrences, pa-
tient quality of life, economic impact, and oncological out-
comes and compare types of treatment by stage and prac-
tice among patients with prostate cancer in Korea. The 
complex studies use well-sorted variables from the K-CaP 
database, together with adjustment methods including 
case controls, standardization, regression trees, and multi-
variate regression approaches for optimal analysis. The 
entry form contains five categories: patient demographics, 
clinical parameters, pathological parameters, other treat-
ment parameters (hormone therapy or radiotherapy), and 
parameters associated with follow-up. The data can be ex-
tracted according to access rights. Access given to an inves-
tigator allows extraction of only his or her patient’s data. 
However, one given data management access can extract 
the whole data set. These two access rights allow the ability 
to extract data through the web system. The data format 
for data extraction includes CSV format, MS Excel (xls for-
mat), or MS Access (accdb format). The System Manager 
is able to select data by accessing the SQL Server system 
directly using the SQL program (Suppl. 2). 
5) Quality control
To ensure the quality of the database, it is most important 
that accurate data be provided by the investigators. 
However, if a strange code is entered into the database, the 
database system automatically checks the input code and 
will not process the input of the strange data set. The stand-
ard input code is determined under the participating inves-
tigators’ agreement. Investigators are also able to compare 
their own raw data with data in the K-CaP database at any-
time, because each institution’s data can be extracted if the 
investigator has access rights. 
3. The e-CRF system for K-CaP
A pilot test was performed to determine whether to use the 
standard e-CRF system based on the limited perioperative 
information of prostate cancer patients who underwent 
radical prostatectomy. Between January 2006 and Decem-
ber 2010, 858 prostate cancer patients who underwent rad-
ical prostatectomy at three institutions (Gangnam Seve-
rance Hospital, Seoul St. Mary’s Hospital, or Seoul Natio-
nal University Bundang Hospital) were registered in the 
e-CRF system of K-CaP. The database collected preopera-
tive variables, including patient age, prostate-specific an-
tigen level at diagnosis, preoperative Gleason score, clin-
ical stage, and the initial procedure chosen for radical 
prostatectomy. Postoperative variables were also regis-
tered, including pathologic Gleason score and stage. For 
each patient, the T stage was determined in accordance 
with tumor-node-metastasis (TNM) categories, as pub-
lished in 2010 (American Joint Committee on Cancer, 7th 
edition). All of the pathologic parameters that influence the 
determination of TNM staging were registered in detail. 
This process is important to prepare for the periodic renew-
al of TNM categories. The first step was to gather the pros-
tate cancer database files from each institution using the 
Excel format and to send these files to an e-CRF system 
manager controlling the data input/output of the 
web-based database. Subsequently, the manager con-
verted the coded Excel files for use in the e-CRF system. 
Finally, we were able to obtain outcomes from the multi-
center e-CRF database according to several conditions that 
we initially established to fit the goals of K-Cap. 
RESULTS 
The multicenter K-CaP test database, which contains data 
for a total of 858 prostate cancer patients who underwent 
radical prostatectomy at three institutions, represents a 
single source for comprehensive information about the pa-
tients and the disease. A Java program was developed to 
upload Excel data into the e-CRF database by matching 
each column name. If the uploaded Excel file executes the 
Java program, the data is automatically entered into the 
designated column. Verification of the upload process can 
be conducted in two steps. The first step is to compare the 
number of records between the uploaded Excel file and the 
SQL Server database. The second step is to transform data 
from the SQL Server into Excel format and then compare 
it with the original data set. 
We established accurate operation of the web-based da-
tabase system without any difficulties. We confirmed that 
the process of converting data to the e-CRF system from 
Excel files is easy and exact and that output data from the 
web-based database system are quickly retrievable accord-
ing to many weighted limitations. 
DISCUSSION
A longitudinal observation database has many advantages 
for prospective studies and research. Complete treatment 
histories and patient information allow for comparison of 
different outcomes. As the number of patients enrolled in 
the database increases, the database will help to categorize 
patients and identify historical controls for various 
purposes. In existing research about prostate cancer, pa-
tients have been selected with indiscriminate consid-
eration of treatment type or stage, regardless of the varying 
aims of specific studies. 
For example, the life expectancy of Korean prostate can-
cer patients with multiple bone metastases is not yet 
known. In addition, we do not yet know the exact clinical 
course of Korean prostate cancer patients after treatment. 
Even though we reviewed the results of many studies and 
made conclusions about disease progression [7-12], the re-
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sults were from single-institution cohort studies with 
small sample sizes. Thus, these studies insufficiently rep-
resent the characteristics of prostate cancer in Koreans. 
Furthermore, despite the many studies of prostate cancer 
in Koreans, most of our knowledge is still based on studies 
from a Western database of prostate cancer. Thus, we need-
ed a prostate cancer database of our own, and we believe 
that K-CaP is that database. However, under a system of 
longitudinal observation, the collection of visible results 
for analysis will require more time than is required for 
studies focusing on retrospective design. We expect that at 
least 5 years will be required to obtain tangible and qual-
itative results from the K-CaP database. If the initial re-
sults are positive, however, lasting products will exist in 
the database on an ongoing basis. In the case of CaPSURE, 
the first published results about trends in prostate cancer 
treatment (2003) were published 7 years after initial devel-
opment of the CaPSURE project. Currently, a PubMeD 
search with the term “CaPSURE” delivers more than 100 
relevant articles, including articles on the J-CaP project in 
Japan.
Achievement of this long-term plan requires verification 
of the web-based database system as the first step toward 
the establishment of K-CaP. The pilot test with prostate 
cancer patient databases from three institutions showed 
the feasibility of a web-based system for K-CaP. The im-
portant checkpoint is that the results of the pilot test are 
not intended to be used to make analytical conclusions 
about the specific subjects from the three institutions. The 
intent of the pilot test was to ensure that the K-CaP data-
base system was operating accurately before other partic-
ipating institutions provided proprietary data. 
As this article goes to press, patient data from the re-
maining institutions in the Korean healthcare system are 
being registered. We estimate that approximately 4,000 
cases from participating institutions will be registered as 
the basic background data for the K-CaP database (620 pa-
tients from Asan Medical Center, J.H.H., C.S.K.; 1,400 pa-
tients from Samsung Medical Center, H.M.L.; 340 patients 
from Seoul National University Bundang Hospital, 
S.K.H., S.S.B.; 300 patients from Seoul St. Mary’s Hospital, 
J.Y.L., S.W.L.; and 1,235 patients from Yonsei University 
Severance Hospital, K.H.R., B.H.C.). The patients with 
newly diagnosed prostate cancer from the participating in-
stitutions will be registered, including the required entry 
information for K-CaP. According to the patients’ privacy 
agreement, basic information about the patients will be en-
crypted by using a program unique to the K-CaP database 
and will remain unknown to our team and even to the data-
base manager. Thus, the privacy of the patients registered 
in K-CaP is guaranteed.
Developing a uniform format for the K-CaP database was 
one of the main concerns of the project staff at each of the 
participating institutions. For example, because of differ-
ent policies at each institution, differences in preoperative 
prostate volume measurements (by transrectal ultra-
sonography) existed between the participating institu-
tions. Some institutions measured prostate volume pre-
operatively in all patients, but the procedure was per-
formed at different clinical stages at some institutions. 
Furthermore, each institution had different postoperative 
follow-up periods over which to conduct patient orientation 
surveys, such as the International Index of Erectile Func-
tion questionnaire. In addition to policy differences be-
tween the institutions, internal problems concerning a uni-
form database format also existed. For example, patholo-
gists at different institutions reported tumor volumes after 
radical prostatectomy differently. Some pathologists re-
ported the precise weights of the tumors in grams, whereas 
others reported approximate volumes using relative meas-
urements (e.g., V1, V2, and V3). Importantly, we previously 
identified several problems, such as those mentioned 
above, and have discussed solutions intended to achieve a 
uniform format for the database. We will continue to revise 
and develop the K-CaP format in an effort to provide the 
flexibility needed to achieve the long-term goals of the 
database. 
Another important consideration in the management of 
the K-CaP database is how best to maintain continuous up-
dates about patients. Data maintenance is the most prac-
tical problem faced by every participant in the database. 
It is difficult to predict how many new prostate cancer pa-
tients from each participating institution will be enrolled 
in K-CaP. Likewise, it is difficult to update K-CaP data pe-
riodically if the number of enrolled patients is too large, 
even before the K-CaP settings are ready. However, it is 
well known that the design of a longitudinal observational 
study ensures that the quality of the data is more important 
than the quantity of the data. To solve this problem, we en-
rolled a limited number of prostate cancer patients repre-
sentative of a particular institution rather than all of the 
prostate cancer patients at that institution. After de-
termining the appropriate K-CaP settings through trial 
and error, we intend to enroll all prostate cancer patients 
in the K-CaP database and to include patients from any in-
stitution that wants to participate in K-CaP. 
One last consideration is the importance of K-CaP’s col-
laboration with CaPSURE and J-CaP. K-CaP is intended 
to be used not only for domestic investigation but also for 
international participation and collaboration. Even thou-
gh K-CaP is still in the preparatory stage, we have already 
received valuable advice and support from the working 
staff and chairmen of CaPSURE and J-CaP. They have 
shown sincere interest in K-CaP and a willingness to 
collaborate. Collaboration will best be achieved if the for-
mat of the K-CaP database is analogous to that of the other 
databases. The K-CaP database was developed consider-
ing the original Excel database of CaPSURE and J-CaP. 
The CaPSURE database has many variables, for which 
each treatment of prostate cancer was equally taken into 
account. In contrast, the J-CaP database focuses on hormo-
nal treatment. This probably reflects the different trends 
in prostate cancer treatment between the United States 
and Japan. The ability to reference these different data-
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bases will help to enrich the K-CaP database, so that our 
database can cover many fields.
In this article, we announced the establishment of K-CaP 
on behalf of all the participants in the K-CaP project. The 
main purpose of K-CaP is to establish and maintain a large 
database of randomized clinical trials and observational 
longitudinal studies of Korean prostate cancer patients. 
Several retrospective studies about prostate cancer in 
Korea have been published in domestic and international 
journals. However, we have always been keenly aware of 
the limitations of retrospective studies. We believe that 
mutual cooperation is needed to establish the K-CaP proj-
ect as being equal to the CaPSURE and J-CaP projects in 
the United States and Japan, respectively. Although our 
beginnings have been humble, we are confident that our 
dedication and ongoing efforts will result in K-CaP becom-
ing a world-renowned longitudinal observation database, 
along with CaPSURE and J-CaP.
CONCLUSIONS
This article announces the development and establish-
ment of K-CaP as the first database for comprehensive data 
collection about prostate cancer patients in Korea for the 
purposes of research and improved patient care. This study 
tested the web-based system of the K-CaP database to ana-
lyze coded Excel files from three institutions. The system 
operated precisely, and the pilot test verified that the 
web-based database system is suitable for K-CaP. The sys-
tem processes will run successfully as long as sufficient and 
updated data is continuously provided to the system 
manager. As soon as possible, complete statistical results 
of registered prostate cancer patients will be reported for 
basic background data. 
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